Options Medical Weight Loss Clinic
3345 E 86th St • Indianapolis, IN 46240
⚙ Telehealth
🔍 Medication confirmed
Last reviewed: March 2026
Listing completeness
100% complete
Name & Address Google Places
Phone Google Places
Website Google Places
Medications clinic website
Telehealth clinic website
Pricing clinic website
About
Located in the heart of Indianapolis, Options Medical Weight Loss Clinic serves patients across Indiana with physician-directed GLP-1 weight loss programs. Available options include treatment with semaglutide (Ozempic/Wegovy) and tirzepatide (Mounjaro/Zepbound), both in-person and virtual telehealth appointments. The clinic is highly rated at 5 stars from 62 patient reviews.
This Clinic May Be a Good Fit If You
- Prefer telehealth consultations from home
- Want in-person visits
- Are looking for Semaglutide, Tirzepatide
- Want medications shipped to your door
- Want a free initial consultation
- Want compounded medication options
- Want transparent, upfront pricing
Clinic Details
Phone(317) 324-4008 ↗
WebsiteVisit Website ↗
Visit Type
In-Person & Telehealth
per clinic website
Medication Type
Compounded
Consultation
Free consultation
Delivery
Medications shipped to your door
Hours
| Mon | 8:00 AM – 5:00 PM |
| Tue | 8:00 AM – 7:00 PM |
| Wed | 8:00 AM – 7:00 PM |
| Thu | 8:00 AM – 7:00 PM |
| Fri | 8:00 AM – 5:00 PM |
Own this clinic? Claim your free listing to update info and receive patient inquiries, or upgrade to Premium for featured placement.
Learn More About GLP-1 Weight Loss
Semaglutide Guide
Ozempic, Wegovy — dosing, side effects, costs
Tirzepatide Guide
Mounjaro, Zepbound — dosing, side effects, costs
Insurance Coverage
Check if your plan covers GLP-1 medications
Savings Calculator
Estimate your monthly medication costs
BMI Calculator
Check your eligibility for GLP-1 treatment
Compare Medications
Side-by-side comparison of all GLP-1 options
Pricing Guide
What to expect for GLP-1 medication costs
Patient Reviews
This clinic has 62 Google reviews (rated 5/5). No reviews submitted on GlobalGLP1 yet — be the first to share your experience.